Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 281Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Multi-regional clinical trials and global drug development

Shenoy Premnath

Year : 2016| Volume: 7| Issue : 2 | Page no: 62-67

   This article has been cited by
1 A novel valuation model for medical intervention development based on progressive dynamic changes that integrates Health Technology Assessment outcomes with early-stage innovation and indication-specific clinical success rates
Jonathan Dando,Maximilian Lebmeier
Journal of Innovation and Entrepreneurship. 2020; 9(1)
[Pubmed]  [Google Scholar] [DOI]
2 Cell-Based Therapies for Stroke: Are We There Yet?
Mirja Krause,Thanh G. Phan,Henry Ma,Christopher G. Sobey,Rebecca Lim
Frontiers in Neurology. 2019; 10
[Pubmed]  [Google Scholar] [DOI]
3 Globalization of clinical trials: Variation in estimated regional costs of pivotal trials, 20152016
Yao Qiao,G Caleb Alexander,Thomas J Moore
Clinical Trials. 2019; 16(3): 329
[Pubmed]  [Google Scholar] [DOI]
4 Acceleration of rare disease therapeutic development: a case study of AGIL-AADC
Sonya Das,Samuel Huang,Andrew W. Lo
Drug Discovery Today. 2019;
[Pubmed]  [Google Scholar] [DOI]
5 Strategic inclusion of regions in multiregional clinical trials
Seung Yeon Song,Deborah Chee,EunYoung Kim
Clinical Trials. 2019; 16(1): 98
[Pubmed]  [Google Scholar] [DOI]
6 Perspectives on Adopting the Guideline for Multi-regional Clinical Trials in Korea: A Multi-stakeholder Survey
Minji Sohn,Yun-Kyoung Song,Ah Young Jeon,Jung Mi Oh,In-Wha Kim
Korean Journal of Clinical Pharmacy. 2019; 29(4): 267
[Pubmed]  [Google Scholar] [DOI]
7 Regulations and Guidelines for Planning and Design of Multi-regional Clinical Trials
Yun-Kyoung Song,Minji Sohn,Ah Young Jeon,Jae Hyun Kim,Eunhee Ji,Jung Mi Oh,In-Wha Kim
Korean Journal of Clinical Pharmacy. 2018; 28(2): 146
[Pubmed]  [Google Scholar] [DOI]
8 Identification of Drug Characteristics for Implementing Multiregional Clinical Trials Including Japan
Mitsuhiro Rokuda,Naoki Matsumaru,Katsura Tsukamoto
Clinical Therapeutics. 2018;
[Pubmed]  [Google Scholar] [DOI]
9 Comparative evidence on harms in pediatric randomized clinical trials from less developed versus more developed countries is limited
Dario Tedesco,Mufiza Farid-Kapadia,Martin Offringa,Zulfiqar A. Bhutta,Yvonne Maldonado,John P.A. Ioannidis,Despina G. Contopoulos-Ioannidis
Journal of Clinical Epidemiology. 2018; 95: 63
[Pubmed]  [Google Scholar] [DOI]


Read this article